O Jänne, A Kauppila, K Kontula, P Syrjälä, R Vihko. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenocarcinoma/drug therapyAdenocarcinoma/metabolismAdultCytosol/analysisEndometrial Hyperplasia/drug therapyEndometrial Hyperplasia/metabolismEndometrium/metabolismEstradiol/bloodFemaleFollicle Stimulating Hormone/bloodHumansLuteinizing Hormone/bloodMedroxyprogesterone/administration & dosageMedroxyprogesterone/pharmacologyMedroxyprogesterone/therapeutic useMiddle AgedProgesterone/bloodProgestins/analysisReceptors, Cell Surface/analysisReceptors, Estrogen/analysisReceptors, Progesterone/analysisUterine Neoplasms/drug therapyUterine Neoplasms/metabolism
Substances: See more » ProgestinsReceptors, Cell SurfaceReceptors, EstrogenReceptors, ProgesteroneProgesteroneEstradiolLuteinizing HormoneFollicle Stimulating HormoneMedroxyprogesterone
Year: 1979 PMID: 231013 DOI: 10.1002/ijc.2910240505
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396